Aster DM Healthcare Limited, one of the largest private healthcare service providers operating in multiple Gulf Cooperation Council (GCC) states, has setup first-of-its-kind ‘clinical simulation lab’ to give boost to clinical real-world evidence across India and Middle East.

The brand has partnered with THB c/o Sekhmet Technologies – a leading real world evidence company across India, GCC, and SEA – to drive data transformation and to deliver clinical evidence and research.

Large quantum of data will provide answers to questions that time bound clinical trials across smaller number of subjects may not be able to provide. The science of leveraging data from the day-to-day clinical practices – also called Real World Evidence – has the power to what eventually is wanted to achieve – COVID-19 eradication. 

Dr Satish Prasad Rath, Chief Innovation & Research Officer, Aster DM Healthcare stated that real world evidence is the need of the hour to study drug efficacy and safety, discover repurposed drugs and drive interventions for personalised patient care and treatment. 

Akansh Khurana, CEO, THB mentioned that they are in the process of setting up the foundation to collect and compile anonymised data on COVID-19 vaccines usage and the associated short-term as well as long-term outcomes.

It is evident that continued insights from millions of datasets from across real world settings is going to be the key asset to continue developing understanding on the nuances of COVID-19, and the behaviours and effect of treatments and vaccinations across the large number of patient groups.